Exploring genetic counselors’ perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM)

Pathogenic germline mutations in the BRCA1 or BRCA2 genes are associated with an elevated lifetime risk for breast (50–85% risk) and ovarian cancer (20–40% risk). Genome-wide association studies have identified over 100 genetic variants associated with modified breast and/or ovarian cancer risk in B...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Genet Couns
Main Authors: Heinlen, Christopher, Hovick, Shelly R., Brock, Guy N., Klamer, Brett G., Ewart Toland, Amanda, Senter, Leigha
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548677/
https://ncbi.nlm.nih.gov/pubmed/30843639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgc4.1079
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares